| |
Overview of ongoing activity of working group on RBDs |
| |
Co-chairs |
| |
RBDs in the USA ( US working group on RBDs) |
| |
A. Shapiro (USA) |
| |
Glanzmann thrombasthenia: World distribution, mutations and founder effects |
| |
U. Seligsohn (Israel) |
| |
Menorrhagia in women affected by RBDs. Proposal of an International study |
| |
F. Peyvandi (Italy) |
| |
Long term prophylaxis in afibrinogenemic patients: a rationale based on results from single dose PK |
| |
T. Waegemans (France) |
| |
Getting products to patients: industry options |
| |
J. Lloyd (UK) |
| |
General discussion: future directions |
| |
|
| |
minute  |
